Accretive Health Reports Inducement Grant under NYSE Rule 303A.08

Thu Apr 4, 2013 7:00am EDT

* Reuters is not responsible for the content in this press release.

CHICAGO--(Business Wire)--
Accretive Health, Inc. (NYSE: AH) today announced that pursuant to the
employment agreement entered into with Stephen Schuckenbrock on April 2, 2013,
the company granted to Mr. Schuckenbrock on April 3, 2013 a non-qualified stock
option under the New York Stock Exchange inducement grant exception. The
inducement grant was approved by the company`s Board of Directors on April 1,
2013 and is being made as an inducement material to Mr. Schuckenbrock`s
acceptance of employment with the company, in accordance with New York Stock
Exchange Rule 303A.08. The company previously announced that Mr. Schuckenbrock
has been appointed President and Chief Executive Officer and a member of the
company's Board of Directors, effective April 3, 2013. 

The stock option is for the purchase of 2,903,801 shares of the company`s common
stock, with an exercise price of $9.56, which was the closing price of the
company`s common stock reported on the New York Stock Exchange on April 3, 2013.
The stock option will vest and become exercisable on a ratable monthly basis
over 48 months based on continued service to the company, subject to
acceleration in specified circumstances. 

Accretive Health is providing the above information regarding Mr.
Schuckenbrock`s inducement grant in accordance with New York Stock Exchange Rule

About Accretive Health

At Accretive Health, our mission is to help our healthcare clients strengthen
their financial stability and deliver better care at a more affordable cost to
the communities they serve (increasing healthcare access to all). For more
information, visit

Accretive Health, Inc.
Investor Relations:
Atif Rahim
Telephone: 312.324.5476
Puneet Singh
Telephone: 330.565.6802

Copyright Business Wire 2013